In outpatients, the World Health Organization recommends that the urine Alere Determine-tuberculosis lipoarabinomannan (AlereLAM) should be used to support the diagnosis of tuberculosis (TB) in people living with HIV (PLHIV) with CD4 counts ≤ 100 cells/µL or with signs of being 'seriously ill'. There is a risk of a false-positive AlereLAM in disseminated non-tuberculous mycobacterial (NTM) infections and it may be difficult to differentiate a single infection (either Mycobacterium tuberculosis or NTM) from dual infection.

中文翻译：

---

Alere 确定播散性非结核分枝杆菌中的结核病脂阿拉伯甘露聚糖阳性：一个说明性病例系列。

在门诊患者中，世界卫生组织建议应使用尿液 Alere determine-tuberculosis lipoarabinomannan (AlereLAM) 来支持 CD4 计数 ≤ 100 个细胞/µL 或有体征的 HIV 感染者 (PLHIV) 的结核病 (TB) 诊断是“重病”。在播散性非结核分枝杆菌 (NTM) 感染中存在假阳性 AlereLAM 的风险，并且可能难以区分单一感染（结核分枝杆菌或 NTM）与双重感染。